Invasive mucinous adenocarcinoma (IMA) is a relatively rare subtype of lung
adenocarcinoma, composed of goblet and/or columnar tumour cells containing abundant …

Introduction An accurate histological evaluation of invasive lung adenocarcinoma is
essential for a correct clinical and pathological definition of the tumour. Different grading …

Purpose: Invasive mucinous adenocarcinoma (IMA) is a unique subtype of lung
adenocarcinoma, characterized genomically by frequent KRAS mutations or specific gene …

Advancements in the classification of lung adenocarcinoma have resulted in significant
changes in pathological reporting. The eighth edition of the tumour–node–metastasis (TNM) …

Aims Mucinous adenocarcinoma arising in congenital pulmonary airway malformation
(CPAM) is a rare complication, with little being known about its natural course. The aims of …

Simple Summary Pulmonary invasive mucinous adenocarcinoma (IMA) is a recognized
variant of lung adenocarcinoma (ADC) that has unique histological patterns …

Background The prognosis of invasive mucinous adenocarcinoma (IMA) remains
controversial and should be clarified by comparison with the International Association for the …

Classification of lung cancer has undergone significant restructuring in the past 20 years,
with four editions from the WHO (1999, 2004, 2015, 2021) in this period. 1–4 For …

Background Invasive mucinous adenocarcinoma (IMA) is distinct from non-mucinous
adenocarcinoma, but studies on recurrent IMA are scarce. Thus, this study aimed to evaluate …

Lung adenocarcinoma staging and grading were recently updated to reflect the link between
histologic growth patterns and outcomes. The lepidic growth pattern is regarded as “in-situ,” …